Dingzhi Dental Completes Hundreds of Millions RMB Series A Funding Round Led by F-Prime Capital
VCBeat has learned that Dingzhi Doctor Group (Shenzhen) Co., Ltd. (hereinafter referred to as “Dingzhi Stomatology” or “Dingzhi”), a leading brand and expert in complex dental implantology in China, has recently completed an A-round financing of hundreds of millions of yuan. This round was exclusively invested by FIL Capital. CEC CAPITAL served as the exclusive financial advisor to Dingzhi Stomatology in this transaction.
China’s dental implant market holds immense potential and room for growth. As public awareness of dental care continues to rise, coupled with demographic shifts in China, demand for oral healthcare services is steadily increasing. The high prevalence of dental diseases among the elderly has further stimulated rigid demand for dental implants. Meanwhile, the implementation of centralized volume-based procurement policies for dental implants is reshaping the landscape of the oral healthcare industry.
Dingzhi Dental was established in 2019, integrating dental medical services, chain management, and supply chain operations, with its headquarters located in Shanghai. The company primarily focuses on dental implant services, while also offering a range of other dental treatment services, including orthodontics, aesthetic restoration, periodontal therapy, pediatric dentistry, and general dentistry. The company boasts a top-tier team specializing in complex implant cases, whose members are the inventors of dozens of national patent technologies for VIIV zygomatic and pterygoid implant procedures, leading technological innovation in the industry.
In the future, Dingzhi will leverage its dental implant services to attract patients, build an industry reputation for high-quality care and innovative implant techniques, and gradually expand into pediatric dentistry, general dentistry, orthodontics, and prosthodontics, thereby achieving comprehensive, full-service development.
In just five years since its establishment, the company has rapidly expanded its business footprint through a dual-drive strategy of self-built chain stores and co-developed specialties, achieving simultaneous growth in both store count and financial performance. Its self-operated clinics are deeply rooted in Shanghai, with a concentrated layout in regions familiar to the management team, such as the Yangtze River Delta and the Pearl River Delta. Notably, the brand’s flagship stores feature substantial individual scales, with significant room for expansion in terms of dental chair capacity and operational floor area, indicating a high growth ceiling. Meanwhile, Dingzhi Dental actively explores opportunities for mergers and acquisitions (M&A) within the industry. Leveraging the team’s extensive management and operational expertise, it swiftly completes post-investment integration and improves operational performance, thereby maximizing M&A value.
Li Qiang, President of Dingzhi Dentalstated: “We appreciate FIL Capital’s recognition of our company. At Dingzhi Dental, customer satisfaction remains our unwavering goal and the driving force behind our continuous technological advancements and service quality improvements.”We look forward to partnering with FIL Capital in the future to jointly fulfill our corporate mission of “making dental implants accessible to all,” and to become a leading enterprise in China’s oral healthcare services sector.”
Miao Yiqing, Executive Director of FIL Capitalstated: “We are delighted to participate in Dingzhi Dental’s Series A financing round. The inclusion of dental implants in the centralized volume-based procurement program has triggered industry-wide transformation, presenting a strategic opportunity for leading dental institutions to further expand their market presence. Dingzhi Dental holds distinct advantages in the standardization and advancement of complex implant procedures, while also possessing independent pricing capabilities and differentiated competitive strengths.”We believe that Dingzhi Dental, leveraging its technological leadership and broad customer reach, is well-positioned to meet growing market demand and continue its robust growth. Meanwhile, FIL Capital remains firmly bullish on China’s health consumer market, which is poised to nurture more high-quality enterprises driven by evolving consumer mindsets, economic development, and demographic shifts.”
Shao Luyao, Executive Director of the Healthcare Investment Banking Team at CEC Capitalstated: “With an industry-leading team of dentists and management professionals, Dingzhi Dental has rapidly grown into a leading healthcare service provider specializing in implantology, despite having been established for only five years.”We are delighted to have assisted Dingzhi Dental in completing this round of financing. We look forward to Dingzhi Dental’s continued steady expansion, bringing greater dental care accessibility to a broader population, and believe that this financing will inject further vitality into the healthcare services sector.”